Dr. Obinna Ikechukwu Ekwunife
Dr. Obinna Ikechukwu Ekwunife is a PROFESSOR in CLINICAL PHARMACY AND PHARMACY MANAGEMENT Department, Faculty Of Pharmaceutical Sciences in Nnamdi Azikiwe University
|  |
Staff Profile
I am a pharmacist and a public health scientist with expertise in health economic evaluation, evidence-based public health and implementation science including the design of cluster randomized trials. I apply these research methods to generate evidence to aid healthcare decisions in developing countries. My research focus is mainly on HIV, neglected tropical diseases, and malaria. I have 42 publications in Scopus-indexed journals (with a Scopus H-index of 13) and 60 published articles (with a Google Scholar H-index of 18). In my current research, I work with a multidisciplinary and multi-country team (at Fred Hutch, Seattle and KEMRI/Jomo Kenyatta University, Kenya) to design and implement differentiated models of HIV PrEP delivery in Kenya and hopefully extended to other sub-Saharan African countries. I am a fellow of the Nigerian Young Academy (NYA), the Alexander von Humboldt Foundation (AVH), and a former Takemi Fellow at Harvard School of Public Health. I am one of the programme managers of the Social Innovation in Health Initiative (SIHI) Nigeria Hub based at Nnamdi Azikiwe University, a World Health Organization/TDR-sponsored project that aims to identify and promote social innovations in health in Nigeria.
Personal Information
Email: | |
Phone: | |
Address: | Clinical Pharmacy And Pharmacy Management, Faculty Of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka. |
Faculty/Unit: | FACULTY OF PHARMACEUTICAL SCIENCES |
Department/Sub-Unit: | CLINICAL PHARMACY AND PHARMACY MANAGEMENT |
Social Profiles
Interest Areas
Academic Qualifications
| Degrees / Basic Certificates | |
|---|---|
| 1 | University of Nigeria Nsukka. (Doctor of Philosophy, January, 2013) January, 2009 to February, 2012 PhD Clinical Pharmacy (Social Pharmacy) |
| 2 | University Of Nigeria Nsukka. (Master Degree, March, 2007) January, 2006 to March, 2007 M.Pharm Clincal Pharmacy |
| 3 | University Of Nigeria Nsukka. (Bachelor Degree, October, 2004) November, 1998 to October, 2004 B.Pharm Pharmacy |
Relevant/Working Experience
| 1 | Grant Coordinator, Nnamdi Azikiwe University October, 2019 to September, 2021 |
| 2 | Faculty Postgraduate Subdean, Nnamdi Azikiwe University May, 2017 to April, 2019 |
| 3 | Head of Department, Nnamdi Azikiwe University December, 2013 to November, 2015 |
Creative Output
| Journal Articles | |
|---|---|
| 1 | Onwunduba A, Ekwunife O, Onyilogwu E.. (2023, December), "Impact of point-of-care c-reactive protein testing intervention on non-prescription dispensing of antibiotics for respiratory tract infections in private community pharmacies in Nigeria: a cluster randomized controlled trial.", International Journal of Infectious Diseases, Vol. 127, pp 137-143 |
| 2 | Nduka IJ, Ejie IL, Okafor CE, Eleje GU, Ekwunife OI. (2023, January), "Interventions to increase mammography screening uptake among women living in low-income and middle-income countries: a systematic review", BMJ Open, Vol. 13 |
| 3 | Bayugo YV, Labarda M, Cruz JRB, Mier-Alpaño JD, Tiangco PMP, Oyene UE, Omoleke SA, Ulitin A, Ong A Jr, Fajardo MS, Echavarria MI, Alger J, Mathanga D, Msiska BK, Ekwunife OI, Nwaorgu O, Abella Lizcano L, Gomez Quenguan N, Nieto Anderson CI, Beltran BY, Carcamo Rodriguez ED, Núñez ES, Nkosi-Kholimeliwa V, Mwafulirwa-Kabaghe G, Juban N.. (2022, June), "Description of global innovative methods in developing the WHO Community Engagement Package.", BMJ Open, Vol. 12 |
| 4 | Ekwunife OI, Anetoh MU, Kalu SO, Ele PU, Egbewale BE, Eleje GU.. (2022, September), "Impact of conditional economic incentives and motivational interviewing on health outcomes of adolescents living with HIV in Anambra State, Nigeria: A cluster-randomised trial.", Contemporary Clinical Trials Communication, Vol. 30 |
| 5 | Nduka IJ, Ejie IL, Okafor CE, Eleje GU, Ekwunife OI. (2022, March), "Interventions to increase mammography screening uptake among women living in low-income and middle-income countries: a protocol for a systematic review", BMJ Open, Vol. 12 |
| 6 | Ekwunife OI, Onubogu CU, Aribodor OB, Anigbogu KC, Ogwaluonye UC, Ekwunife CA, Okunna CS, Nwaorgu O. (2022, April), "Approaching healthcare delivery through a new lens: a crowdsourcing challenge to identify health-related social innovations to increase universal health coverage in Nigeria", BMJ Innovation, Vol. 8 |
| 7 | Akunne MO, Heise TL, Ukwe CV, Okonta MJ, Anosike C, Ekwunife OI. (2022, July), "Satisfaction of Nigerian Patients with Health Services: A Systematic Review", Nigerian Journal of Medicine, Vol. 32, (Issue 3) |
| 8 | Ekwunife OI, Ejie IL, Okelu V, Mita C, Durosinmi-Eti O, Powell A.. (2022, December), "Interventions to increase the uptake and continuation of pre-exposure prophylaxis (PrEP) by adolescent girls and young women at high risk of HIV in low-income and middle-income countries: a scoping review", BMJ Global Health, Vol. 7 |
| 9 | Ekwunife OI, Ofomata CJ, Okafor CE, Anetoh MU, Kalu SO, Ele PU, Eleje GU. (2021, July), "Cost-effectiveness and Feasibility of Conditional Economic Incentives And Motivational Interviewing To Improve HIV Health Outcomes of Adolescents Living With HIV In Anambra State, Nigeria.", BMC Health Service Research, Vol. 21, (Issue 1), pp 685 |
| 10 | Okafor C, Ekwunife OI. (2021, August), "Cost-benefit analysis of introducing rotavirus vaccine in eight sub-Saharan African Countries", Lancet Global Health, Vol. 9, (Issue 8), pp e1088-e1100 |
| 11 | Ejie IL, Eleje GU, Chibuzor M, Anetoh MU, Nduka IJ, Umeh IB, Ogbonna BO, Ekwunife OI. (2021, June), "A systematic review of qualitative research on barriers and facilitators to exclusive breasfeeding practice in sub-Saharan African countries", International Breastfeeding Journal, Vol. 16, (Issue 1), pp 44 |
| 12 | Semeeh Akinwale Omoleke, Yolanda V. Bayugo, Ukam Ebe Oyene, Jonathan Abrahams, Nina Gobat, Suvajee Good, Mary Manandhar, Samar Elfeky, Ana Gerlin Hern. (2021, July), "WHO Community Engagement Package: A Reinforcement of an Inclusive Approach to Global Public Health", International Journal of Epidemiology and Health Sciences, Vol. 2, (Issue 7), pp e16 |
| 13 | Okafor C, Ekwunife OI. (2021, February), "Promoting the integrated community case management of under-five pneumonia in Nigeria: a cost-effectiveness analysis", Cost Effectiveness and Resource Allocation, Vol. 19, (Issue 1), pp 12, doi: 10.1186/s12962-021-00265-9 |
| 14 | Nwinyi OC, Osariyekemwen U, Awosanya EJ, Oyeyemi IT, Ugbenyen AM, Muhammad A, Alabi OA, Ekwunife OI, Adetunji CO, Omoruyi IM. (2020, November), "Review of drinking water quality in Nigeria: towards attaining the sustainable development goal six", Annals of Science and Technology, Vol. 5, (Issue 2), pp 58-77, doi: https://doi.org/10.2478/ast-2020-0014 |
| 15 | Isah AUJ, Ekwunife OI, Ejie IL, Mandrik O. (2020, August), "Effects of nutritional supplements on the re-infection rate of soil-transmitted helminths in school-age children: A systematic review and meta-analysis", PLoS One, Vol. 15, (Issue 8), pp e0237112, doi: 10.1371/journal.pone.0237112 |
| 16 | Akunne MO, Okonta MJ, Ukwe CV, Heise TL, Ekwunife OI. (2019, November), "Satisfaction of Nigerian patients with health services: a protocol for a systematic review", Systematic Reviews, Vol. 8, (Issue 1), pp 256 |
| 17 | Mandrik O, Ekwunife OI, Meheus F, Severens JLH, Lhachimi S, Uyl-de Groot CA, Murillo R. (2019, September), "Systematic reviews as a "lens of evidence": Determinants of cost-effectiveness of breast cancer screening", Cancer Medicine, Vol. 8, (Issue 18), pp 7846-7858, doi: 10.1002/cam4.2498 |
| 18 | Oli AN, Akunna PE, Ekwunife OI, Okoye EL, Anyaoku CS, Ibeanu GC, Obi E, Ihekwereme CP, Objai M. (2019, January), "Pleurotus ostreatus extract enhances the phagocytic actions of neutrophils against Streptococcus pneumoniae", Annals of Medical and Health Sciences Research, Vol. 9, pp 499-508 |
| 19 | Ekwunife OI, Anetoh MU, Kalu SO, Ele PU, Eleje GU. (2018, December), "Conditional economic incentives and motivational interviewing to improve adolescents' retention in HIV care and adherence to antiretroviral therapy in Southeast Nigeria: study protocol for a cluster randomised trial", Trials, Vol. 19, (Issue 1), pp 710, doi: 10.1186/s13063-018-3095-4 |
| 20 | Okafor CE, Ekwunife OI. (2017, December), "Cost-effectiveness analysis of diarrhoea management approaches in Nigeria: A decision analytical model.", PLoS Neglected Tropical Disease, Vol. 11, (Issue 12), pp e0006124, doi: 10.1371/journal.pntd.0006124 |
| 21 | Ekwunife OI, Lhachimi SK. (2017, December), "Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage", BMC Health Service Research, Vol. 17, (Issue 1), pp 815, doi: 10.1186/s12913-017-2758-2 |
| 22 | Anyakora C., Ekwunife O., Alozie F., Esuga M., Ukwuru J., Onya S., Nwokike J. (2017, September), "Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post- certification of a Nigerian pharmaceutical manufacturer", BMC Health Services Research, Vol. 17, (Issue 1), pp 665, DOI 10.1186/s12913-017-2610-8 |
| 23 | Mandrik O, Ekwunife OI, Zielonke N, Meheus F, Severens JL, Lhachimi SK, Murillo R. (2017, June), "What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviews", Systematic Reviews, Vol. 6, (Issue 1), pp 122, doi: 10.1186/s13643-017-0510-y |
| 24 | Sweiti H, Ekwunife O, Jaschinski T, Lhachimi SK. (2017, January), "Repurposed therapeutic agents targeting the Ebola virus: a systematic review", Current Therapeutic Research, Vol. 84, pp 10-21, DOI: http://dx.doi.org/10.1016/j.curtheres.2017.01.007 |
| 25 | Ekwunife OI, O’Mahony JF, Gerber Grote A, Mosch C, Tatjana P, Lhachimi SK. (2016, April), "Distinct challenges in the cost-effectiveness analysis modelling of HPV vaccines in low- and middle-income countries: A systematic review and practice recommendation", Vaccine Research |
| 26 | Khan Z, Khan S, Christianson L, Rehman S, Ekwunife O, Samkange-Zeeb F. (2016, December), "Smokeless tobacco and oral potentially malignant disorders in South Asia: a systematic review and meta-analysis. Nicotine Tobacco Research", Nicotine and Tobacco Research, Vol. 20, (Issue 1), pp 12-21, doi: 10.1093/ntr/ntw310 |
| 27 | Ekwunife OI, O'Mahony JF, Gerber Grote A, Mosch C, Paeck T, Lhachimi SK. (2016, September), "Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations", Pharmacoeconomics, Vol. 35, (Issue 1), pp 65-82, https://pubmed.ncbi.nlm.nih.gov/27637758/ |
| 28 | Khan Z, Khan S, Christianson L, Rehman S, Ekwunife O, Samkange-Zeeb F. (2016, August), "Smokeless tobacco and oral potentially malignant disorders in South Asia: a protocol for a systematic review", Systematic Reviews, Vol. 5, (Issue 1), pp 142, doi: 10.1186/s13643-016-0320-7 |
| 29 | Umeh BI, Nduka SO, Ekwunife OI. (2016, June), "Mothers' Willingness to Pay for HPV Vaccines in Anambra State, Nigeria: A Cross Sectional Contingent Valuation Study", Cost Effectiveness and Resource Allocation, Vol. 14, pp 1-8, BMC |
| 30 | Ekwunife OI, Ezenduka CC, Uzoma BE. (2016, January), "Evaluating the sensitivity of EQ-5D in a sample of patients with type 2 diabetes mellitus in two tertiary health care facilities in Nigeria", BMC Research Notes, Vol. 9, (Issue 24), doi:10.1186/s13104-015-1832-2 |
| 31 | Sweiti H, Ekwunife O, Jaschinski T, Lhachimi SK. (2015, November), "Repurposed therapeutic agents targeting the Ebola virus: a protocol for a systematic review", Systematic Reviews, Vol. 4, (Issue 1), pp 171, doi: 10.1186/s13643-015-0153-9 |
| 32 | Ekwunife OI, Gerber Grote A, Mosch C, O’Mahony JF, Lhachimi SK. (2015, May), "Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review", Systematic Reviews, Vol. 4, pp 68, doi:10.1186/s13643-015-0057-8 |
| 33 | Offu O, Anetoh M, Okonta M, Ekwunife O. (2015, November), "Engaging Nigerian community pharmacists in public health programs: assessment of their knowledge, attitude and practice in Enugu metropolis.", Journal of Pharmaceutical Policy and Practice, Vol. 8, (Issue 27), doi: 10.1186/s40545-015-0048-0 |
| 34 | Oreh CN, Ekwunife OI. (2014, February), "Ignorance about Chlamydia compared to gonorrhoea infection among sexually active people in Nigeria", International Journal of Health Promotion and Education, Vol. 53, (Issue 6), pp 284-290 |
| 35 | Okoye MO, Ukwe VC, Okoye TC, Adibe MO, Ekwunife OI. (2014, October), "Satisfaction of HIV patients with pharmaceutical services in South Eastern Nigerian hospitals", International Journal of Clinical Pharmacy, Vol. 36, (Issue 5), pp 914-921, doi: 10.1007/s11096-014-0006-y |
| 36 | Ezenduka CC, Ogbonna BO, Ekwunife OI, Okonta MJ, Esimone CO. (2014, June), "Drugs use pattern for uncomplicated malarial in medicine retail outlets of Enugu urban, southeast Nigeria: implications for malaria treatment policy", Malaria Journal, Vol. 13, (Issue 1), pp 243 |
| 37 | Ekwunife OI, Aguwa CN. (2014, April), "Cost-effectiveness analysis of interventions to improve control of high blood pressure in low resource settings: the case of Nigeria", Cardiology and Angiology: The International Journal, Vol. 2, (Issue 2), pp 87-101, DOI: 10.9734/CA/2014/10292 |
| 38 | Okafor CE, Ekwunife OI. (2014, March), "Self-reported adherence to antiretroviral therapy in sub-Saharan Africa: A meta-analysis", International Journal of Public Health and Epidemiology, Vol. 3, (Issue 3), pp 17-25 |
| 39 | Oreh NC, Esimone CO, Ekwunife OI. (2013, January), "Prevalence and susceptibility patterns of clinical isolates of Escherichia coli to various antimicrobials in a clinical microbiology laboratory in South-south Nigeria", African Journal of Clinical and Experimental Microbiology, Vol. 14, (Issue 1), pp 23-28 |
| 40 | Ekwunife OI, Okafor CE, Ezenduka CC and Udeogaranya PO. (2013, January), "Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis", Cost Effectiveness and Resource Allocation, Vol. 11, (Issue 1), pp 2, doi: 10.1186/1478-7547-11-2 |
| 41 | Ekwunife OI, Aguwa CN, Igboeli NU. (2012, March), "Health Utilities Index Mark 3 (HUI3) demonstrated construct validity in a Nigerian population with hypertension", Health and Quality of Life Outcomes, Vol. 22, (Issue 2), pp 455-458, doi: 10.1007/s11136-012-0150-6 |
| 42 | Ubaka CM, Ekwunife OI, Adibe MO. (2012, August), "Does the clinical clerkship course improve students' attitudes towards pharmaceutical care?", International Journal of Pharmacy Practice, Vol. 20, (Issue 4), pp 4272-274, https://doi.org/10.1111/j.2042-7174.2012.00191.x |
| 43 | Ekwunife OI, Oreh C, Ubaka CM. (2012, October), "Concurrent use of complementary and alternative medicine with antiretroviral therapy reduces adherence to HIV medications", International Journal of Pharmacy Practice, Vol. 20, (Issue 5), pp 340-343, doi: 10.1111/j.2042-7174.2012.00204.x |
| 44 | Njilele AC, Ukwe CV, Okonta JM, Ekwunife OI. (2012, February), "Development of a patient satisfaction questionnaire for HIV/AIDS patients in Nigeria", International Journal of Clinical Pharmacy, Vol. 34, (Issue 1), pp 98-104, Doi:10.1007/s11096-011-9596-9 |
| 45 | Ekwunife OI, Okafor CE, Ezenduka CC. (2012, June), "Cost-utility analysis of antihypertensive medications in Nigeria: A decision analysis", International Society for Pharmacoepidemiology Conference, Barcelona, Spain |
| 46 | Ekwunife OI, Aguwa CN, Adibe MO, Barikpoar E, Onwuka C. (2011, December), "Health state utilities of a population of Nigerian hypertensive patients", BMC Research Notes, Vol. 12, (Issue 4), pp 528, doi: 10.1186/1756-0500-4-528 |
| 47 | Ekwunife OI, Aguwa CN. (2011, December), "A meta analysis of prevalence rate of hypertension in Nigerian populations", Journal of Public Health and Epidemiology, Vol. 3, (Issue 13), pp 604-607, https://doi.org/10.5897/JPHE.9000002 |
| 48 | Ekwunife OI, Ubaka CM. (2011, January), "Drug utilization review of antihypertensive therapy among patients with compelling indications in two hospital in South-Eastern Nigeria", Journal of Pharmacy and Pharmacological Research, Vol. 2, (Issue 1), pp 25-28 |
| 49 | Ukwe CV, Ekwunife OI, Ayogu E and Adibe MO. (2010, January), "Cost-effectiveness study of Artemether-lumefantrine, artesunate-amodiaquine and dihydoartemisinin-piperaquine in the treatment of uncomplicated malaria in a Nigerian Hospital", Drug Invention Today, Vol. 2, (Issue 10), pp 429-432 |
| 50 | Igboeli NU, Ukwe CV, Ekwunife OI. (2010, October), "Increasing use of artemisinin-based combination therapy for treatment of malaria infection in Nigerian hospitals", Pharmacy Practice (Granada), Vol. 8, (Issue 4), pp 243-249, doi: 10.4321/s1886-36552010000400007 |
| 51 | Ukwe CV, Ekwunife OI, Epueke EA, Ubaka CM. (2010, December), "Antimalarial Activity of Ageratum conyzoides in combination with Chloroquine and Artesunate.", Asian Pacific Journal of Tropical Medicine, Vol. 3, (Issue 12), pp 412-420, https://doi.org/10.1016/S1995-7645(11)60005-9 |
| 52 | Ekwunife OI, Udeogaranya PO, Nwatu IL. (2010, July), "Prevalence, awareness, treatment and control of hypertension in a Nigerian population.", Health, Vol. 2, (Issue 7), pp 731-735, doi:10.4236/health.2010.27111 |
| 53 | Ukwe CV, Epueke EA, Ekwunife OI, Okoye TC, Akudor GC, Ubaka CM. (2010, January), "Antimalarial activity of aqueous extract and fractions of leaves of Ageratum conyzoides in mice infected with Plasmodium berghei", International Journal of Pharmaceutical Sciences, Vol. 2, (Issue 1), pp 33-38 |
| 54 | Ekwunife OI, Ukwe CV, Awanye AM. (2010, January), "Knowledge and treatment seeking pattern of malaria infection in Abakaliki, Ebonyi State", Research Journal of Pharmaceutical, Biological and Chemical Sciences, Vol. 1, (Issue 2), pp 317-323 |
| 55 | Ekwunife OI, Udeogaranya PO, Adibe MO. (2010, May), "Predictors of self reported adherence to antihypertensive medication in a Nigerian Population", Journal of Basic and Clinical Pharmacy, Vol. 1, (Issue 12), pp 133-138 |
| 56 | Ukwe CV, Ekwunife OI, Udeogaranya PO, Iwuamadi UI. (2010, July), "Self-reported adherence to HAART in south-eastern Nigeria is related to patients’ use of pill box", Journal of Social Aspects of HIV/AIDS, Vol. 7, (Issue 1), pp 94-99, DOI: 10.1080/17290376.2010.9724950 |
| 57 | Oyim EK, Ibezim EC, Okoye TC, Esimone CO, Brown SA, Ekwunife OI. (2009, December), "In-vivo studies on the bioequivalence of some brands of Ofloxacin and levo-floxacin tablets marketed in Nigeria", International Journal of drug development and Research, Vol. 1, (Issue 1), pp 110-116 |
| 58 | Ukwe CV, Udeogaranya PO, Ekwunife OI. (2009, July), "Pharmacoeconomic comparison of treatments for the eradication of Helicobacter Pylori in Enugu State, Nigeria", Journal of Pharmaceutical Research, Vol. 8, (Issue 3), pp 125-129, Doi: 10.18579/JPCRKc/2009/8/3/79727 |
| 59 | Udeogaranya PO, Ukwe CV, Ekwunife OI. (2009, July), "Assessment of attitudes of University of Nigeria Pharmacy Students toward pharmaceutical care", Pharmacy Practice (Granada), Vol. 7, (Issue 3), pp 145-149 |
| 60 | Adibe MO, Ukwe CV, Ekwunife OI. (2009, May), "Evaluation of therapeutic uses of aloe barbadensis miller (aloe Vera) plant among staff and students in a Nigerian university", International Journal of Pharmaceutical Sciences, Vol. 30, pp 107-110 |
| 61 | Ukwe CV, Ekwunife OI. (2008, October), "Drug Utilisation Study of antimalarials for the treatment of hosptialized children under five in South-Eastern Nigeria", Pharmacoepidemiology and Drug Safety, Vol. 17, (Issue 12), pp 1183-1188, doi: 10.1002/pds.1669 |
| 62 | Aguwa CN, Ukwe CV, Ekwunife OI. (2007, August), "Effects of Pharmaceutical care programme on blood pressure and quality of life in a Nigerian Pharmacy", Pharmacy World Science, Vol. 30, pp 107-110, doi: 10.1007/s11096-007-9151-x |
| 63 | Okonta JM, Momoh MA, Ekwunife OI, Mbagwu ISU, Abali S. (2007, October), "Assessment of HIV/AIDS Awareness and Changing of Sexual Practices among Secondary School Students in Nsukka Environment", Tropical Doctor, Vol. 37, pp 269-271, DOI: 10.1258/004947507782333071 |
| Conference Papers | |
| 1 | Ezennia IJ, Ekwunife OI. (2016, October), "Cost-benefit analysis of malaria rapid diagnostic test in Enugu metropolis, Nigeria: the perspective of the community pharmacy practitioner", 8th EDCTP Forum, Lusaka, Zambia |
| 2 | Ekwunife OI. (2014, November), "Satisfaction of HIV Patients with Pharmacy Services in South Eastern Nigerian Hospitals", ISPOR |
| 3 | Ekwunife OI, Ubaka CM. (2010, October), "Drug Utilization Review of Antihypertensive Therapy among Patients with Compelling Indications in Two Hospitals in South-Eastern Nigeria", International Society for Pharmacoepidemiology Conference, Brighton, UK, Vol. 19, pp S264 |
Academic Leadership Qualities
| Supervisions | |
|---|---|
| 1 | "Extent of public health activities in community pharmacies in Enugu Metropolis" (2015). Completed Masters project by Ogochukwu Offu |
| 2 | "Mothers’ willingness to pay for HPV vaccines in Anambra State, Nigeria: a cross-sectional contingent valuation study" (2016). Completed Masters project by Ifeoma Umeh |
| 3 | "Cost-benefit analysis of malaria rapid diagnostic test in community pharmacy in Enugu Metropolis" (2016). Completed Masters project by Ifeoma Ezennia |
| 4 | "Antibiotics utilization in a Nigerian Tertiary Hospital" (2017). Completed Masters project by Temedie Tarilate |
| 5 | "Cost-effective approach in management of diarrhea in Nigeria: a decision analytical model" (2016). Completed Masters project by Chukwuebuka Okafor |
| 6 | "Assessing effective mechanisms to improve HIV Adolescents' Adherence to Antiretroviral Therapy and Retention in Care in South-east Nigeria" (2021). Completed Doctorate project by Maureen Ugonwa Anetoh |
| 7 | "Development of an educational intervention to improve pharmaceutical care practice in Anambra State: a simulated patient study" (2021). Completed Doctorate project by Nneoma Okpalanwa |
| Grants | |
| 1 | Awardee: "Takemi Fellowship in International Health - Harvard School of Public Health" (December, 2021 to May, 2022). Completed sponsored grant by Japanese Pharmaceutical Association |
| 2 | Collaborator: "Social Innovation in Health (SIHI) grant" (April, 2020 to December, 2021). Completed sponsored grant by World Health Organization |
| 3 | Awardee: "EDCTP Career Development Fellowship" (June, 2018 to May, 2021). Completed sponsored grant by European and Developing Countries Clinical Trial Partnership (EDCTP) |
| 4 | Awardee: "Georg Forster Return Fellowship" (October, 2016). Completed sponsored grant by Alexander von Humboldt Foundation |
| 5 | Awardee: "Georg Forster Research Fellowship" (August, 2014 to September, 2016). Completed sponsored grant by Alexander von Humboldt Foundation |
| Editorships | |
| 1 | Editor, "Plos One" (January, 2021) |
| 2 | Editor, "Hindawi - Biomed Research International" (January, 2021) |
| Examinerships | |
| 1 | Chief Examiner, "Health Policy and Administration" (July, 2021). Ongoing External Exam |
Membership of Professional/Relevant Bodies
| 1 | Fellow Member, "Alexander Von Humboldt Foundation" - https://www.humboldt-foundation.de/en/ (member since 2018), https://www.humboldt-foundation.de/en/ |
| 2 | Fellow Member, "Nigerian Young Academy" - https://nigerianyoungacademy.org/aboutus/fellows (member since 2016), https://nigerianyoungacademy.org/ |
| 3 | Full Member, "African Research Network for Neglected Tropical Diseases (ARNTD)" - https://arntd.org/team/obinna-ekwunife/ (member since 2015), https://arntd.org/team/obinna-ekwunife/ |